NUMB controls p53 tumour suppressor activity

Nature

Volumn 451, Issue 7174, 2008, Pages 76-80

  Colaluca, Ivan N ^a,b   Tosoni, Daniela ^a,b   Nuciforo, Paolo ^a   Senic Matuglia, Francesca ^a   Galimberti, Viviana ^b   Viale, Giuseppe ^b,c   Pece, Salvatore ^a,b,c   Di Fiore, Pier Paolo ^a,b,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ALPHA TUBULIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CISPLATIN; DOXORUBICIN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NOTCH RECEPTOR; NUMB PROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PUMA PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VINCULIN;

GENE; PHENOTYPE; PROTEIN; TUMOR;

ARTICLE; BREAST TUMOR; CANCER CELL; CANCER CHEMOTHERAPY; CELL CYCLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DAMAGE; ENDOCYTOSIS; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MITOSIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

EID: 38049046724     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06412     Document Type: Article

References (33)

1. Roegiers, F. & Jan, Y.N. Asymmetric cell division. Curr. Opin. Cell Biol. 16,195-205(2004).
2. Santolini, E. et al. Numb is an endocytic protein. J. Cell Biol. 151, 1345-1352 (2000).
3. Berdnik, D., Torok, T., Gonzalez-Gaitan, M. & Knoblich, J.A. The endocytic protein α-adaptin is required for numb-mediated asymmetric cell division in Drosophila. Dev. Cell 3, 221-231 (2002).
4. Hutterer, A. & Knoblich, J. A. Numb and α-adaptin regulate Sanpodo endocytosis to specify cell fate in Drosophila external sensory organs. EMBO Rep. 6, 836-842 (2005).
5. Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell Biol. 167, 215-221 (2004).
6. Vousden, K. H. & Prives, C. p53 and prognosis: new insights and further complexity. Cell 120, 7-10 (2005).
7. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
8. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
9. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
10. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997).
11. Zhang, Y., Xiong, Y. & Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734 (1998).
12. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. & Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83 (1992).
13. Sherr, C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991(1998).
14. McCann, A. H. et al. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br. J. Cancer 71, 981-985 (1995).
15. Pharoah, P. D., Day, N. E. & Caldas, C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br. J. Cancer 80, 1968-1973 (1999).
16. ARF expression in invasive breast cancers and ductal carcinoma in situ-relationships to p53 and Hdm2. Breast Cancer Res. 6, R571-R585 (2004).
17. Sharpless, N. E. & DePinho, R. A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9, 22-30 (1999).
18. ARF expression in breast cancer. Oncogene 20, 4586-4590 (2001).
19. Silva, J. et al. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. J. Pathol. 199, 289-297 (2003).
20. Juven-Gershon, T. et al. The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol. Cell. Biol. 18, 3974-3982 (1998).
21. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004).
22. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (1998).
23. Paull, T. T. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886-895 (2000).
24. Reis, T. & Edgar, B. A. Negative regulation of dE2F1 by cyclin-dependent kinases controls cell cycle timing. Cell 117, 253-264 (2004).
25. Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
26. Fish, K. N., Schmid, S. L. & Damke, H. Evidence that dynamin-2 functions as a signal-transducing GTPase. J. Cell Biol. 150, 145-154 (2000).
27. Enari, M., Ohmori, K., Kitabayashi, I. & Taya, Y. Requirement of clathrin heavy chain for p53-mediated transcription. Genes Dev. 20, 1087-1099 (2006).
28. Sharpless, N. E. & DePinho, R. A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160-168 (2004).
29. Sherley, J. L., Stadler, P. B. & Johnson, D. R. Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc. Natl Acad. Sci. USA 92, 136-140 (1995).
30. Rambhatla, L., Ram-Mohan, S., Cheng, J. J. & Sherley, J. L. Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells. Cancer Res. 65, 3155-3161 (2005).
31. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003).
32. Woelk, T. et al. Molecular mechanisms of coupled monoubiquitination. Nature Cell Biol. 8, 1246-1254 (2006).
33. Veronesi, U. et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 349, 546-553 (2003).